June 30th 2025
The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.
From the Formulator to the Tablet Manufacturing Floor: Desiderata and Troubleshooting
October 1st 2001Tablet manufacturers often overlook critical basic concepts or established practices. The author draws from his own experiences and discusses how solid dosage manufacturers can improve production and product quality by optimizing major unit operations.
Current Status of Drug Delivery Technologies and Future Directions
February 2nd 2001Evolution of an existing drug molecule from a conventional form to a novel delivery system can significantly improve its performance in terms of patient compliance, safety, and efficacy. These days,drug delivery companies are engaged in the development of multiple platform technologies to get competitive advantage, extend patent life, and increase market share of their products.